Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Rasayana Tx ingests GI candidate in $36M deal
Rasayana is paying Theriva Biologics $300,000 upfront for an oral intestinal alkaline phosphatase meant to restore balance to inflamed guts.
Darren Incorvaia
Feb 18, 2026 10:40am
Sensei steps back from brink by finding Faeth merger
Feb 18, 2026 10:33am
Sponsored
Carl Sailer on AI, market trends, and strategic planning in biotech
Oct 28, 2024 8:00pm
Novartis finds natural partnership in macrocycle biotech
Feb 18, 2026 10:13am
Sponsored
Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization
Oct 28, 2024 8:00am
Fierce Biotech Fundraising Tracker '26: Korsana, ILiAD & more
Feb 18, 2026 9:30am